Anitox; Filing of Food Additive Petition (Animal Use); Formaldehyde, 58603 [E8-23723]
Download as PDF
<![CDATA[
Federal Register / Vol. 73, No. 195 / Tuesday, October 7, 2008 / Notices
through community-based
organizations, Tribes and Village
governments. The purpose of ANA is to
promote the goal of economic and social
self-sufficiency for American Indians,
Native Hawaiians, Alaskan Natives and
other Native American Pacific Islanders,
including American Samoa Natives.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
2. Priority Area Description for
Economic Development
The FY2009 PA Priority Area
Description for Economic Development
Projects adds the following bullet:
• Projects to promote traditional
energy activities and practices that
support conservation and help to
mitigate the high costs associated with
the purchase, transportation, and
storage of fuel in remote Alaskan
Villages.
AGENCY:
mstockstill on PROD1PC66 with NOTICES
3. Priority Area Description for Social
Development
The FY 2009 PA Priority Area
Description for Social Development
Projects removes the following bullets:
• Projects to reduce child/infant
abuse and neglect and family domestic
violence.
• Projects that address the needs of
grandparents raising grandchildren.
• Projects to recruit, train and certify
new Native American foster parents or
promote appropriate extended family
placements or to assist abused,
neglected and abandoned Native
American children, youth and their
families.
(D) ANA ERE: The FY 2009 PA
includes an additional instruction in the
Approach evaluation criterion, Project
Strategy sub-criterion. This change
reflects the need for additional
information related to the land area and
natural resources over which the
applicant has jurisdiction. (Legal
authority: Section 803(a) and (d) and
803C of the Native American Programs
Act of 1974, as amended, 42 U.S.C.
2991b and 2991b–3 and Pub. L. 109–
394.)
The FY 2009 PA Approach evaluation
criterion, Project Strategy sub-criterion
will have the following statement
added:
Applicants are required to describe a
land base or other resources, e.g., river
or body of water, over which they
exercise jurisdiction to implement
Tribal regulation of environmental
quality. Maps and photos of the area are
encouraged.
Dated: September 30, 2008.
Quanah Crossland Stamps,
Commissioner, Administration for Native
Americans.
[FR Doc. E8–23662 Filed 10–6–08; 8:45 am]
BILLING CODE 4184–01–P
VerDate Aug<31>2005
18:23 Oct 06, 2008
Jkt 217001
Food and Drug Administration
[Docket No. FDA–2008–F–0518]
Anitox; Filing of Food Additive Petition
(Animal Use); Formaldehyde
Food and Drug Administration,
HHS.
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing
that Anitox has filed a petition
proposing that the food additive
regulations be amended to provide for
the safe use of formaldehyde to retard
the growth of Clostridium perfringens in
animal feeds.
DATES: Submit written or electronic
comments on the petitioner’s
environmental assessment December 8,
2008.
ADDRESSES: Submit written comments
to the Division of Dockets Management
(HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852. Submit
electronic comments to https://
www.regulations.gov.
FOR FURTHER INFORMATION CONTACT:
Isabel W. Pocurull, Center for Veterinary
Medicine, Food and Drug
Administration, 7519 Standish Pl.,
Rockville, MD 20855, 240–453–6853,
e-mail: isabel.pocurull@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: Under the
Federal Food, Drug, and Cosmetic Act
(section 409(b)(5) (21 U.S.C. 348(b)(5)),
notice is given that a food additive
petition (FAP 2259) has been filed by
Anitox, 1055 Progress Circle,
Lawrenceville, GA 30043. The petition
proposes to amend the food additive
regulations in part 573—Food Additives
Permitted in Feed and Drinking Water
of Animals (21 CFR part 573) to provide
for the safe use of formaldehyde to
retard the growth of Clostridium
perfringens in animal feeds.
The potential environmental impact
of this action is being reviewed. To
encourage public participation
consistent with regulations issued under
the National Environmental Policy Act
(40 CFR 1501.4(b)), the agency is
placing the environmental assessment
submitted with the petition that is the
subject of this notice on public display
at the Division of Dockets Management
(see DATES and ADDRESSES) for public
review and comment.
Interested persons may submit to the
Division of Dockets Management (see
ADDRESSES) written or electronic
comments regarding this document.
PO 00000
Frm 00075
Fmt 4703
Sfmt 4703
58603
Submit a single copy of electronic
comments or two paper copies of any
mailed comments, except that
individuals may submit one paper copy.
Comments are to be identified with the
docket number found in brackets in the
heading of this document. Received
comments may be seen in the Division
of Dockets Management between 9 a.m.
and 4 p.m., Monday through Friday.
FDA will also place on public display
any amendments to, or comments on,
the petitioner’s environmental
assessment without further
announcement in the Federal Register.
If, based on its review, the agency finds
that an environmental impact statement
is not required and this petition results
in a regulation, the notice of availability
of the agency’s finding of no significant
impact and the evidence supporting that
finding will be published with the
regulation in the Federal Register in
accordance with 21 CFR 25.51(b).
Please note that on January 15, 2008,
the FDA Division of Dockets
Management Web site transitioned to
the Federal Dockets Management
System (FDMS). FDMS is a
Government-wide, electronic docket
management system. Electronic
comments or submissions will be
accepted by FDA only through FDMS at
https://www.regulations.gov.
Dated: September 29, 2008.
Bernadette Dunham,
Director, Center for Veterinary Medicine.
[FR Doc. E8–23723 Filed 10–6–08; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2008–N–0038]
Endocrinologic and Metabolic Drugs
Advisory Committee; Notice of
Meeting; Correction
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice; correction.
SUMMARY: The Food and Drug
Administration is correcting a notice
that appeared in the Federal Register of
September 24, 2008 (73 FR 55114). The
document announced a forthcoming
meeting of a public advisory committee
of the Food and Drug Administration
(FDA). A portion of the meeting will be
closed to the public. This document
corrects the error.
FOR FURTHER INFORMATION CONTACT:
Theresa Green, Office of the
Commissioner, Food and Drug
E:\FR\FM\07OCN1.SGM
07OCN1
]]>Agencies
[Federal Register Volume 73, Number 195 (Tuesday, October 7, 2008)]
[Notices]
[Page 58603]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-23723]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2008-F-0518]
Anitox; Filing of Food Additive Petition (Animal Use);
Formaldehyde
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing that
Anitox has filed a petition proposing that the food additive
regulations be amended to provide for the safe use of formaldehyde to
retard the growth of Clostridium perfringens in animal feeds.
DATES: Submit written or electronic comments on the petitioner's
environmental assessment December 8, 2008.
ADDRESSES: Submit written comments to the Division of Dockets
Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane,
rm. 1061, Rockville, MD 20852. Submit electronic comments to https://
www.regulations.gov.
FOR FURTHER INFORMATION CONTACT: Isabel W. Pocurull, Center for
Veterinary Medicine, Food and Drug Administration, 7519 Standish Pl.,
Rockville, MD 20855, 240-453-6853, e-mail: isabel.pocurull@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: Under the Federal Food, Drug, and Cosmetic
Act (section 409(b)(5) (21 U.S.C. 348(b)(5)), notice is given that a
food additive petition (FAP 2259) has been filed by Anitox, 1055
Progress Circle, Lawrenceville, GA 30043. The petition proposes to
amend the food additive regulations in part 573--Food Additives
Permitted in Feed and Drinking Water of Animals (21 CFR part 573) to
provide for the safe use of formaldehyde to retard the growth of
Clostridium perfringens in animal feeds.
The potential environmental impact of this action is being
reviewed. To encourage public participation consistent with regulations
issued under the National Environmental Policy Act (40 CFR 1501.4(b)),
the agency is placing the environmental assessment submitted with the
petition that is the subject of this notice on public display at the
Division of Dockets Management (see DATES and ADDRESSES) for public
review and comment.
Interested persons may submit to the Division of Dockets Management
(see ADDRESSES) written or electronic comments regarding this document.
Submit a single copy of electronic comments or two paper copies of any
mailed comments, except that individuals may submit one paper copy.
Comments are to be identified with the docket number found in brackets
in the heading of this document. Received comments may be seen in the
Division of Dockets Management between 9 a.m. and 4 p.m., Monday
through Friday. FDA will also place on public display any amendments
to, or comments on, the petitioner's environmental assessment without
further announcement in the Federal Register. If, based on its review,
the agency finds that an environmental impact statement is not required
and this petition results in a regulation, the notice of availability
of the agency's finding of no significant impact and the evidence
supporting that finding will be published with the regulation in the
Federal Register in accordance with 21 CFR 25.51(b).
Please note that on January 15, 2008, the FDA Division of Dockets
Management Web site transitioned to the Federal Dockets Management
System (FDMS). FDMS is a Government-wide, electronic docket management
system. Electronic comments or submissions will be accepted by FDA only
through FDMS at https://www.regulations.gov.
Dated: September 29, 2008.
Bernadette Dunham,
Director, Center for Veterinary Medicine.
[FR Doc. E8-23723 Filed 10-6-08; 8:45 am]
BILLING CODE 4160-01-S
